Strategic Investment

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.

The global bakery's arrival at Metro Centre signals a new era for the area's dining scene and a major win for developer David S. Brown's strategic vision.

With $4M GTD, Americas Cardroom's High Five series is back, now featuring elite 'Highest Five' events to attract pros alongside its inclusive schedule.

A European consortium has won €1.3M to develop a precision therapy for chronic urticaria, offering new hope for millions with uncontrolled symptoms.

AI cloud specialist CoreWeave raises another $1 billion in high-yield debt, doubling down on its aggressive expansion to meet insatiable AI demand.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

Contrary to hype, AI in drug discovery demands more physical lab work. A new report names Carterra a key winner in this surprising new paradigm.

Liberty Mutual Investments is anchoring Square Nine Capital, a new firm led by industry veterans, to unlock value in complex middle-market deals.

A new partnership combines clinical care with logistical support, aiming to solve the caregiving puzzle for employers and their increasingly stressed employees.

QuEra Computing has released Tsim, a powerful open-source simulator designed to tackle a major bottleneck in building fault-tolerant quantum computers.

Two investment giants are partnering with operator Sentral, betting big on a tech-forward, hospitality model to capitalize on a turbulent housing market.

A Georgia firm's painless patch technology earns top honors, promising to revolutionize medicine delivery and solve critical global health challenges.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

API security leader Wallarm appoints a new executive team, pivoting to tackle the growing security risks of enterprise AI transformation and global expansion.

With a new CEO driven by a personal mission, Cylinder Health aims to scale its virtual care model in the booming, high-cost digestive health market.

With promising clinical data for its lead drug silevertinib and a strong new financial position, Black Diamond Therapeutics charts a dual course for two deadly cancers.

The packaging firm hit 8 figures in its first year. Now, it's doubling down on China with new AI-driven factories to serve global DTC brands.

A new catalytic fund aims to bridge Africa's critical early-stage funding gap, turning high-risk green projects into bankable assets for a sustainable future.

Dr. Pietro Garbelli's award-winning book offers a crucial roadmap for responsibly integrating AI, balancing high-tech innovation with patient trust.